Patents Assigned to SG CORPORATION
  • Composition for preventing or treating diseases caused by caffeine abuse including Evodia officinalis extract or evodiamine as active ingredient
    Patent number: 11219658
    Abstract: The present invention relates to a composition which is for preventing or treating caffeine abuse and includes evodiamine or Evodia officinalis extract. More specifically, the present invention relates to a pharmaceutical composition which has an effect of preventing or alleviating somnipathy and central nervous system excitation caused by caffeine. In addition, the present invention relates to a caffeine abuse treatment method and a health functional food composition including Evodia officinalis extract or evodiamine.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: January 11, 2022
    Assignees: SG CORPORATION, Research and Business Foundation Sungkyunkwan University
    Inventor: Choon Gon Jang
  • COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY CAFFEINE ABUSE INCLUDING EVODIA OFFICINALIS EXTRACT OR EVODIAMINE AS ACTIVE INGREDIENT
    Publication number: 20190314440
    Abstract: The present invention relates to a composition which is for preventing or treating caffeine abuse and includes evodiamine or Evodia officinalis extract. More specifically, the present invention relates to a pharmaceutical composition which has an effect of preventing or alleviating somnipathy and central nervous system excitation caused by caffeine. In addition, the present invention relates to a caffeine abuse treatment method and a health functional food composition including Evodia officinalis extract or evodiamine.
    Type: Application
    Filed: December 1, 2017
    Publication date: October 17, 2019
    Applicants: SG CORPORATION, Research & Business Foundation Sungkyunkwan University
    Inventor: Choon Gon JANG